Tax Reliefs on Research & Development
Fri 11 Oct 2024 2:00 PM - 4:00 PM BST
Online, Zoom
Description
This course looks at Research and Development Claims from a practical level, taking into account the developments over the last 24 months including FA2023 and also HMRC’s enforcement action. Stung by the level of fraud and misrepresentation in R&D claims, HMRC is taking robust action in terms of assessments to disqualify R&D claims as well as opening serious investigations which include criminal proceedings.
Unlike other courses it also looks at the case law developments in the courts and how this will affect future R&D claims.
Prices: £190 + VAT for the first delegate. This is a per organisation price, so up to 10 of your colleagues from the same organisation can participate at no extra charge, even if they are viewing it from a different location or at a different time. So for example, if there are 10 of you the cost per delegate would be just £19.00 each.
For firms with 4 or less partners or sole practitioners, the price for a single ticket is £99
Course Summary
April 2023 saw the most radical changes to Research & Development tax reliefs since the inception of the R&D Expenditure Credit.
The trend for increasing deductions for small companies was dramatically reversed. In response to increased concerns about fraudulent claims the compliance regime has been tightened with new disclosure requirements and responsibilities.
Recent arrests for allegedly fraudulent R&D claims have also highlighted the role that agents have in complying not only with tax legislation but also the code of conduct of their professional regulatory body.
Tax reliefs for R&D still remain an attractive incentive to carry out R&D in the UK. One, however needs to recognise the changing rules on R&D and also the further changes that are due to take place in 2024.
Training Objectives
To equip participants with the necessary skills to identify R&D opportunities and to give them an understanding of the principles underlying R&D claims and how they are changing over the next 12 months.
The course will be of interest to anyone who either advises on R&D expenditure claims or is required to review them as part of the process to file a CT600. This would include auditors, tax advisors and in-house staff.
Course Content
The course will cover:
• Principles of R&D – what qualifies for relief – looking beyond the pharmaceutical industry.
• The Small Company Intensive R&D Regime. Which companies qualify under the Small Company Intensive R&D Regime and the choice between CT deductions and credits.
• The Large Company Regime. The impact of the increases in credits on the regime.
• Claiming for sub contracted work – the parameters and limitations and changes in the rules.
• The new territorial limitations. How these will work and what R&D outside the UK can still be claimed.
• Advance reporting requirements and digital reporting. The new regime which started on 8th August 2023.
• Structuring an R&D Report. How to make the report credible and accurate.
• Common errors. HMRC has given guidance on common errors and claims. We review the actions to avoid.
• Agent’s responsibilities when signing CT600. Often the agent responsible for preparing the CT600 may not have been involved in the original R&D report. We look at the level of responsibilities on all parties.
Our presenter is Jeremy Mindell. Jeremy has been lecturing in taxation for over 20 years. Known on the circuit as an accomplished and entertaining speaker, Jeremy is in high demand for tax, pensions, share schemes and remuneration events. He has developed a specialism in International Corporate Tax, including the new Diverted Profits Tax, transfer pricing and the OECD BEPS project. Jeremy is one of the few individuals in the country who has both qualified as a Chartered Tax Advisor but also has a Masters from the Chartered Institute of Personnel Development. Jeremy worked for three big four firms focusing on employment taxation, expatriate tax, International tax, profit related pay, US taxation and share schemes and HMRC investigations. Following this Jeremy worked at AMP and Henderson Global Investors where he was a Director of the Pension Scheme. He is on the IFS Pro-Share advisory panel and a member of the Worshipful Company of Tax Advisors’ panel.